CombiMatrix Launches Targeted Array for Prenatal Analysis
16 déc. 2014 08h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 16, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Promotes Karine Hovanes, Ph.D., to Vice President of Scientific Advancement and Laboratory Director, and Trilochan Sahoo, M.D., to Vice President of Clinical Affairs and Director of Cytogenetics
19 nov. 2014 08h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 19, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Enters IVF Market With Launch of CombiPGS(TM)
18 nov. 2014 08h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Reports Third Quarter 2014 Financial and Operating Results
04 nov. 2014 16h05 HE
|
CombiMatrix Corporation
– Reports Record Revenue, Cash Reimbursement and Test Volumes –
– Company to Host Conference Call and Webcast Today at 1:30 p.m. PST –
IRVINE, Calif., Nov. 4, 2014 (GLOBE...
CombiMatrix Corporation to Release Third Quarter Financial Results on November 4, 2014
28 oct. 2014 16h05 HE
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 28, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its third quarter 2014 financial results on Tuesday, November 4, 2014....
Data to be Presented at ASHG 2014 Show That Miscarriage Analysis by Chromosomal Microarray Yields a Successful Result in More Than 85% of Cases
14 oct. 2014 08h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 14, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Reports Preliminary Growth in Prenatal Microarray Testing Volumes of 71% and 64% for the Third Quarter and Year-to-Date, Respectively
07 oct. 2014 08h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 7, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Announces Payor Contract With Blue Cross Blue Shield of Illinois
08 sept. 2014 08h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 8, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for pre- and post-natal developmental...
CombiMatrix Reports Second Quarter 2014 Financial and Operating Results
06 août 2014 16h05 HE
|
CombiMatrix Corporation
- Reports Record Revenue and Test Volumes -
- Company to Host Conference Call and Webcast at 1:30 p.m. PDT, Today, August 6, 2014 -
IRVINE, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- CombiMatrix...
CombiMatrix's SNP-Based Miscarriage Analysis Test Granted Conditional Approval From New York State Department of Health
31 juil. 2014 08h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer...